Published in Int Immunol on June 21, 2005
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med (2003) 4.53
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res (2006) 1.45
The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells. J Immunol (2007) 1.18
IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells. Int Immunol (2006) 0.85
Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans. Arterioscler Thromb Vasc Biol (2013) 0.85
Modulation of immune responses - strategies for optimising vaccines. Expert Opin Biol Ther (2004) 0.81
Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides. PLoS One (2012) 0.80
Early activation events differentiate the reactivity of two T-cell families to Staphylococcus enterotoxin A. Cell Immunol (2003) 0.77
Emotional growth--helping children and families "bounce back". Aust Fam Physician (2005) 0.77
Functional effects of adiponectin on endothelial progenitor cells. Obesity (Silver Spring) (2010) 0.75